Article
Pharmacokinetics and absolute bioavailability of lansoprazole.
European journal of clinical pharmacology - 1 Jan 1996
Gerloff J, Mignot A, Barth H, Heintze K
Abstract excerpt
OBJECTIVE: In a crossover study 12 healthy volunteers received lansoprazole 15 mg or 30 mg orally, or 15 mg intravenously in randomized order as a single dose. Blood samples were taken and plasma levels of lansoprazole were determined using an HPLC method. The volunteers were phenotyped for the debrisoquine/sparteine and mephenytoin polymorphisms. RESULTS: The total clearance was 517 ml.min-1, and the absolute...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
